This treatment regimen has the potential to deliver faster healing and shorter hospital stays, consistent with the benefits of our flagship RECELL System and our overall mission." AVITA Medical is currently enrolling participants in the Cohealyx I trial, a post-market study designed to further evaluate clinical outcomes, wound bed preparation for definitive closure, and patient recovery timelines when Cohealyx is used in the management of full-thickness wounds. The Cohealyx I trial underscores AVITA Medical's commitment to generating robust clinical data supporting the benefits and cost-effectiveness of its products. About AVITA Medical, Inc. AVITA Medical ® is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery.